pyrroles has been researched along with Bile Duct Obstruction, Intrahepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, J; Davignon, J; Martineau, P; McPherson, R; Nozza, A; Simoneau, D; Tedgui, A | 1 |
| Crook, MA; Wierzbicki, AS | 1 |
1 trial(s) available for pyrroles and Bile Duct Obstruction, Intrahepatic
| Article | Year |
|---|---|
Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Canada; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Time Factors; Treatment Outcome; Triglycerides | 2008 |
1 other study(ies) available for pyrroles and Bile Duct Obstruction, Intrahepatic
| Article | Year |
|---|---|
Cholestatic liver dysfunction.
Topics: Anticholesteremic Agents; Atorvastatin; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Diagnosis, Differential; Heptanoic Acids; Humans; Liver Function Tests; Male; Middle Aged; Pyrroles | 1999 |